- Home
- ESQ vs NBTX Comparison
ESQ vs NBTX Comparison
Compare ESQ & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ESQ | NBTX |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 941.0M | 1.0B |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ESQ | NBTX |
|---|---|---|
| Price | $115.73 | $32.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $120.33 | $36.00 |
| AVG Volume (30 Days) | ★ 100.9K | 42.9K |
| Earning Date | 04-23-2026 | 03-31-2026 |
| Dividend Yield | ★ 0.69% | N/A |
| EPS Growth | ★ 14.20 | N/A |
| EPS | ★ 5.87 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $28.65 | $58.17 |
| Revenue Next Year | $4.95 | N/A |
| P/E Ratio | $19.77 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $78.93 | $3.13 |
| 52 Week High | $119.86 | $41.89 |
Technical Indicators
Market Signals| Indicator | ESQ | NBTX |
|---|---|---|
| Relative Strength Index (RSI) | 59.77 | 51.26 |
| Support Level | $92.21 | $20.11 |
| Resistance Level | $118.39 | $34.66 |
| Average True Range (ATR) | 3.68 | 1.87 |
| MACD | 0.36 | 0.04 |
| Stochastic Oscillator | 73.87 | 50.31 |
Price Performance
Historical ComparisonAbout ESQ Esquire Financial Holdings Inc.
Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.